logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Early TNBC: is carboplatin plus taxane an alternative to anthracycline plus taxane?

Phase 2 RCT finds adjuvant carboplatin plus taxane is noninferior to standard.